about
A Phase I Trial of HS-10241 in Solid TumorsA Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate CancerA Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerA Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain MetastasesCPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced CancersCANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell CarcinomaA Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsSafety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced MalignanciesA Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyA Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerStudy to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
P6153
Q61862184-B336EE3B-5A46-4507-BD67-08D90E831847Q61862188-85EDAFBC-F4E6-4F4E-AC5C-E6ED5BCC6D3FQ61975328-4980D638-C728-46B3-8593-50C942FA3080Q62034171-D4925F1B-F407-4A5B-A53E-C5F089CF9594Q63399906-68997EF5-4D3D-4619-A42D-CD1236B3D24EQ63400522-761BB48E-C5F7-442D-B0C8-E9841C688863Q63404887-6B7B2820-B12B-491D-9501-AC0AB5018084Q63405227-49CC8FE2-0F67-450B-B0EA-F4AE696AA2FBQ63535194-74E0ABC4-69BE-4F76-9095-0D822ACFE593Q63572962-EC151352-BD50-422E-A4BB-AC9B78392602Q63573590-CAB8C34A-A935-4956-9992-12BFECC4DBE9Q64139366-D6EF8020-6173-43BA-8897-B8C95A04EF2FQ64151539-9D491100-B2DB-48A8-A9E7-CF12B00F51FCQ64151685-8D4DAFDC-93C3-49D3-974E-4FBF338E9E2B
P6153
description
australische Non-Profit-Organisation
@de
nonprofit organization in Camperdown, Australia
@en
name
Chris O’Brien Lifehouse
@en
type
label
Chris O’Brien Lifehouse
@en
prefLabel
Chris O’Brien Lifehouse
@en
P131
P17
P2427
grid.419783.0
P571
2009-01-01T00:00:00Z
P625
Point (151.182196 -33.890501)